Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Bionic breast implant to restore touch and reduce chronic pain after mastectomy

Official title: Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy

Run by University of Chicago · NCT06382272 · Data updated 2026-11-12

This project will try a bionic breast implant that stimulates nerves to restore touch and reduce chronic pain for adults having bilateral mastectomy with two-stage (tissue expander) reconstruction.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment8 (estimated)
SponsorUniversity of Chicago
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedMay 14, 2025
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedApril 27, 2026
Trial IDNCT06382272 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for bilateral mastectomy with two-stage tissue-expander reconstruction at the University of Chicago who can speak English or Spanish, have a cell phone for study contact, and do not require adjuvant chemotherapy are ideal candidates.

Probably not a fit

Patients who need adjuvant chemotherapy, who are having single-stage reconstruction, who have clinical bilateral breast cancer, or who are otherwise poor surgical candidates may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will receive a neuroprosthetic bionic breast implant placed during reconstruction after bilateral mastectomy and will have targeted neural stimulation intended to restore touch sensation. The study will collect safety, sensation, pain, and acceptability data during the implant period and through planned removal of the tissue expander 12–20 weeks after implantation. Outcomes will include measures of touch perception, changes in chronic post-mastectomy pain, and participant-reported experience with the device. Data are intended to inform future feasibility, safety, and efficacy trials of this approach.

Why it matters

Potential benefit: If successful, the device could restore some breast sensation and reduce chronic post-mastectomy pain for participants.

How similar studies have gone: Neuroprosthetic approaches have shown promise in restoring sensation or reducing chronic pain in other body areas, but applying a neuroprosthesis to restore breast sensation after mastectomy is novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* 18 years of age or older
* Scheduled for bilateral mastectomy with two-stage (tissue expander) reconstruction at UCM
* Bilateral mastectomy for unilateral in situ or T1to T2, clinically, N0 (no lymph node involvement) breast cancer or breast cancer risk reduction due to known elevated breast cancer risk. (Note - 19-34% of women choosing mastectomy for small unilateral breast cancer elect bilateral mastectomy.)40 We will enroll from this cohort.
* Agrees to have breast tissue expander removed within 12-20 weeks of implantation.
* Has access to a cell phone and willing to provide the research interviewer with the cell phone number
* Agrees to receive text messages from the study
* Able to speak and understand English or Spanish
* Able to participate in the informed consent process

Exclusion criteria:

* Requires adjuvant chemotherapy
* Single stage mastectomy and reconstruction procedure
* Clinical evidence of bilateral breast cancer
* Clinical evidence of lymph node involvement
* Prior history of mastectomy or other major breast surgery
* Prior history of radiation to the chest area (e.g., mantle radiation for Hodgkin's disease)
* Prior history of injury (e.g., trauma, surgery, burn) that the participant perceives to have had an effect on the sensation of the breast
* Pregnant or intending to become pregnant during the study period
* Pacemaker, defibrillator or other implanted electrical stimulation device that may be affected by the implanted electrodes
* Complex regional pain syndrome or other pain syndromes or a history of a neurologic condition like multiple sclerosis, degenerative neurological disease, cognitive impairment or dementia
* Uncontrolled diabetes
* History of poor wound healing or chronic skin ulcerations
* History of uncontrolled infection or active infection at time of consent
* Expectation that MRI will be required while the devices are implanted
* Inability or unwillingness to follow verbal instructions and comply with study procedures
* Untreated or poorly managed physical or mental health condition that may pose additional risk according to clinical judgment of the patient's breast surgeon or surgeons
* Unwillingness to undergo psychological evaluation to determine study eligibility, if requested or required by surgeons or investigators

Where it's running

  • University of Chicago Medicine Comprehensive Cancer Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.